Horizon Therapeutics Public Ltd Co

CITADEL ADVISORS LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

4,149,825

Value ($000)

480,093

Weight

0.5%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	480,093	0.5%	4,149,825	9/30/2023
2023 Q2	8/14/2023	459,030	0.5%	4,463,101	6/30/2023
2023 Q1	5/15/2023	434,160	0.5%	3,978,009	3/31/2023
2022 Q4	2/14/2023	144,064	0.2%	1,265,940	12/31/2022
2022 Q3	11/14/2022	168,899	0.2%	2,729,034	9/30/2022
2022 Q2	8/15/2022	36,204	0.0%	453,909	6/30/2022
2022 Q1	5/16/2022	18,450	0.0%	175,366	3/31/2022
2021 Q4	2/14/2022	130,964	0.1%	1,215,327	12/31/2021
2021 Q3	11/15/2021	198,174	0.2%	1,809,149	9/30/2021
2021 Q2	8/16/2021	162,219	0.2%	1,732,363	6/30/2021
2021 Q1	5/21/2021	88,187	0.1%	958,133	3/31/2021
2020 Q4	2/16/2021	46,735	0.1%	638,890	12/31/2020
2020 Q3	11/16/2020	99,815	0.1%	1,284,957	9/30/2020
2020 Q2	8/14/2020	204,659	0.3%	3,682,250	6/30/2020
2020 Q1	5/15/2020	106,562	0.2%	3,597,652	3/31/2020
2019 Q4	2/14/2020	49,487	0.1%	1,367,025	12/31/2019